Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.50 EUR
651.36 M EUR
5.64 B EUR
1.26 B
About TERUMO CORP
Sector
Industry
CEO
Hikaru Samejima
Website
Headquarters
Tokyo
Founded
1921
ISIN
JP3546800008
FIGI
BBG000C4GK50
Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of TUO is 19.10 EUR — it has decreased by −2.55% in the past 24 hours. Watch TERUMO CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange TERUMO CORP stocks are traded under the ticker TUO.
TUO stock has risen by 1.60% compared to the previous week, the month change is a 7.30% rise, over the last year TERUMO CORP has showed a 29.93% increase.
We've gathered analysts' opinions on TERUMO CORP future price: according to them, TUO price has a max estimate of 23.61 EUR and a min estimate of 19.21 EUR. Watch TUO chart and read a more detailed TERUMO CORP stock forecast: see what analysts think of TERUMO CORP and suggest that you do with its stocks.
TUO stock is 3.16% volatile and has beta coefficient of 0.74. Track TERUMO CORP stock price on the chart and check out the list of the most volatile stocks — is TERUMO CORP there?
Today TERUMO CORP has the market capitalization of 28.58 B, it has increased by 0.37% over the last week.
Yes, you can track TERUMO CORP financials in yearly and quarterly reports right on TradingView.
TERUMO CORP is going to release the next earnings report on Feb 6, 2025. Keep track of upcoming events with our Earnings Calendar.
TUO earnings for the last quarter are 0.12 EUR per share, whereas the estimation was 0.14 EUR resulting in a −10.72% surprise. The estimated earnings for the next quarter are 0.16 EUR per share. See more details about TERUMO CORP earnings.
TERUMO CORP revenue for the last quarter amounts to 1.57 B EUR, despite the estimated figure of 1.55 B EUR. In the next quarter, revenue is expected to reach 1.62 B EUR.
TUO net income for the last quarter is 183.16 M EUR, while the quarter before that showed 196.55 M EUR of net income which accounts for −6.81% change. Track more TERUMO CORP financial stats to get the full picture.
TERUMO CORP dividend yield was 0.81% in 2023, and payout ratio reached 30.77%. The year before the numbers were 1.12% and 33.61% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 30, 2024, the company has 30.59 K employees. See our rating of the largest employees — is TERUMO CORP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TERUMO CORP EBITDA is 1.52 B EUR, and current EBITDA margin is 22.88%. See more stats in TERUMO CORP financial statements.
Like other stocks, TUO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TERUMO CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TERUMO CORP technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TERUMO CORP stock shows the strong buy signal. See more of TERUMO CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.